Journal for ImmunoTherapy of Cancer

An anti-mesothelin targeting antibody drug conjugate induces pyroptosis and ignites antitumor immunity in mouse models of cancer
Nicole L Wittwer, Alexander H Staudacher, Vasilios Liapis, Pina Cardarelli, Harriet Warren, Michael P Brown

Journal for ImmunoTherapy of Cancer Mar 2023, 11 (3) e006274; DOI: 10.1136/jitc-2022-006274
Systemic inflammatory syndromes as life-threatening side effects of immune checkpoint inhibitors: case report and systematic review of the literature
Lisa L Liu, Marcus Skribek, Ulrika Harmenberg, Marco Gerling

Journal for ImmunoTherapy of Cancer Mar 2023, 11 (3) e005841; DOI: 10.1136/jitc-2022-005841
Interaction between tumor cell TNFR2 and monocyte membrane-bound TNF-α triggers tumorigenic inflammation in neuroblastoma
Julie A Tomolonis, Xin Xu, Kshiti H Dholakia, Chunchao Zhang, Linjie Guo, Amy N Courtney, Siyue Wang, Julien Balzeau, Gabriel A Barragán, Gengwen Tian, Erica J Di Pierro, Leonid S Metelitsa

Journal for ImmunoTherapy of Cancer Mar 2023, 11 (3) e005478; DOI: 10.1136/jitc-2022-005478
Evaluation of tumor antigen-specific antibody responses in patients with metastatic triple negative breast cancer treated with cyclophosphamide and pembrolizumab
Eric D Routh, Mark G Woodcock, Wolfgang Beckabir, Steven P Vensko, Jonathan S Serody, Benjamin G Vincent

Journal for ImmunoTherapy of Cancer Mar 2023, 11 (3) e005848; DOI: 10.1136/jitc-2022-005848
In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade
Chenkai Mao, Veronique Beiss, Gregory W Ho, Jennifer Fields, Nicole F Steinmetz, Steven Fiering

Journal for ImmunoTherapy of Cancer Dec 2022, 10 (12) e005834; DOI: 10.1136/jitc-2022-005834
TIGIT blockade repolarizes AML-associated TIGIT⁺ M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis
Franziska Brauneck, Brit Fischer, Marius Witt, Jana Muschhammer, Jennyfer Oelrich, Pedro Henrique da Costa Avelar, Sophia Tsoka, Lars Bullinger, Elisa Seubert, Daniel J Smit, Carsten Bokemeyer, Christin Ackermann, Jasmin Wellbrock, Friedrich Haag, Walter Fiedler

Journal for ImmunoTherapy of Cancer Dec 2022, 10 (12) e004794; DOI: 10.1136/jitc-2022-004794
Targeting CD89 on tumor-associated macrophages overcomes resistance to immune checkpoint blockade
Lijun Xu, Bingyu Li, Chenyu Pi, Zhaohua Zhu, Fei Tao, Kun Xie, Yan Feng, Xiaoqing Xu, Yanxin Yin, Hua Gu, Jianmin Fang

Journal for ImmunoTherapy of Cancer Dec 2022, 10 (12) e005447; DOI: 10.1136/jitc-2022-005447
Preconditioning of the immune system modulates the response of papillary thyroid cancer to immune checkpoint inhibitors
Fabiana Pani, Yoshinori Yasuda, Sylvie T Rousseau, Kevin C Bermea, Solmaz Roshanmehr, Rulin Wang, Srinivasan Yegnasubramanian, Patrizio Caturegli, Luigi Adamo

Journal for ImmunoTherapy of Cancer Dec 2022, 10 (12) e005538; DOI: 10.1136/jitc-2022-005538
Dose–response correlation for CAR-T cells: a systematic review of clinical studies
Anand Rotte, Matthew J Frigault, Ayub Ansari, Brad Gliner, Christopher Heery, Bijal Shah

Journal for ImmunoTherapy of Cancer Dec 2022, 10 (12) e005678; DOI: 10.1136/jitc-2022-005678
Gallic acid induces T-helper-1-like T_reg cells and strengthens immune checkpoint blockade efficacy
Biaolong Deng, Biaolong Yang, Jieqiong Chen, Shuaiwei Wang, Weiqi Zhang, Yixian Guo, Yichao Han, Hecheng Li, Yongjun Dang, Yaqin Yuan, Xueyu Dai, Yuansheng Zang, Yangyang Li, Bin Li

Journal for ImmunoTherapy of Cancer Jul 2022, 10 (7) e004037; DOI: 10.1136/jitc-2021-004037

Main menu

Journal for ImmunoTherapy of Cancer

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Journal for ImmunoTherapy of Cancer

Pages